Related Experiment Video
Updated: May 29, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Epidemiology of invasive meningococcal disease in Austria 2010
Georg Steindl1, Yu-Lun Liu, Daniela Schmid
1Austrian Agency for Health and Food Safety, National Reference Centre for Meningococci, Graz, Austria. georg.steindl@ages.at
Introduction:
Neisseria meningitidis is a leading cause of meningitis and sepsis worldwide. Thus, monitoring the epidemiology of invasive meningococcal disease (IMD) is an important public health measure. The National Reference Centre for Meningococci at the Austrian Agency for Health and Food Safety is operating the laboratory-based surveillance database.
Methods:
IMD isolates from all over Austria are collected at the National Reference Centre for Meningococci, where the microorganism is characterised by serological and molecular methods, as well as by antimicrobial susceptibility testing. These laboratory-based surveillance data from 1995 to 2010 were analysed by time, place and person. Long-term and seasonal trends were analysed by log-linear regression, yielding an annual average percentage change (AAPC), and by cyclic regression models, applying either a simple linear or a negative binomial regression, including one sine and one cosine term.
Results:
Over the past 16 years, IMD incidence ranged between 0.73 and 1.41/100,000 persons, with a decreasing trend in Serogroup B IMD incidence (AAPC: -2.1%; p = 0.0396) and an increasing trend in Serogroup C IMD incidence (AAPC: +4.3%; p = 0.043). In 2010, 80 cases of IMD were recorded, corresponding to an incidence of 0.95/100,000 population. Ten deaths were registered, which results in a case-fatality of 12.5% and a mortality incidence of 0.12/100,000 population. The predominant serogroup in Austria was serogroup B, followed by serogroups C, Y and W-135.
Discussion:
Although the incidence of IMD in 2010 is below the average incidence rate over the last 15 years, serogroup C IMD in Austria is increasing. Within the previous 10 years two provinces initiated vaccination campaigns for a monovalent meningococcal conjugate vaccine, following the increasing trend of Sg C IMD incidence. An ongoing study on the impact of these vaccination campaigns on the IMD burden will yield further scientific evidence for supporting the introduction of this vaccine into the publicly funded childhood immunisation program.
Insights
Invasive meningococcal disease (IMD) surveillance in Austria shows a declining trend for Serogroup B but an increasing trend for Serogroup C. This highlights the need for targeted vaccination strategies against meningococcal disease.
Area of Science:
- Epidemiology
- Public Health
- Microbiology
Background:
- Neisseria meningitidis is a primary cause of meningitis and sepsis globally.
- Monitoring invasive meningococcal disease (IMD) is crucial for public health.
- A laboratory-based surveillance database is maintained by the Austrian National Reference Centre for Meningococci.
Purpose of the Study:
- To analyze the epidemiology of IMD in Austria from 1995 to 2010.
- To identify trends in IMD incidence by serogroup, time, place, and person.
- To inform public health interventions and vaccination strategies.
Main Methods:
- Laboratory-based surveillance data from IMD isolates across Austria (1995-2010).
- Characterization using serological and molecular methods, and antimicrobial susceptibility testing.
- Statistical analysis including log-linear regression for long-term trends and cyclic regression for seasonal patterns.
Main Results:
- IMD incidence varied between 0.73 and 1.41/100,000 persons over 16 years.
- Serogroup B IMD incidence showed a decreasing trend (AAPC: -2.1%), while Serogroup C increased (AAPC: +4.3%).
- In 2010, 80 IMD cases were recorded; Serogroup B was predominant, followed by C, Y, and W-135.
Conclusions:
- Despite overall incidence below the 15-year average in 2010, Serogroup C IMD is rising in Austria.
- Vaccination campaigns targeting Serogroup C have been initiated in two provinces.
- Further research on vaccination impact may support inclusion in public childhood immunization programs.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis
Bacterial Meningitis II: Pathophysiology
Cryptococcal Meningitis
Viral Meningitis
Infectious Diseases and Their Occurrence

